Context Share Price

Context Share Price

NASDAQ: CNTX | Micro Cap | Healthcare
$0.16
-$0.00 (-2.92%) Last updated on 19 Nov, 2026 | 00:54 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Context Stock Performance

Open
$0.17
Prev. Close
$0.17
Circuit Range
N/A
Day Range
$0.16 - $0.18
Year Range
$0.15 - $3.60
Volume
15,808
Average Traded
$0.16

Context Share Price Today

As of 19 November 2026, Context Therapeutics Inc.'s share price is $0.16. The stock opened at $0.17, compared to its previous close of $0.17. During today's trading session, Context Therapeutics Inc.'s share price traded between $0.16 and $0.18, with an average price of $0.17. Over the past 52 weeks, the stock has recorded a high of $3.60 and a low of $0.15. In terms of performance, Context Therapeutics Inc.'s share price has declined by 94.30% over the last six months and is down 85.46% on a year-on-year basis.

Context Share Price Chart

Line chart of the Context price trend over the selected period. The price fell overall, ranging from 0.16 to 0.17, ending at 0.16.
$0.16$0.18
L
Show Current Price
H

Context Stock Fundamentals & Key Indicators

Market Cap
$15.51M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.48
Revenue (TTM)
$0.00
Return On Equity (TTM)
-141.55%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
41.52%

Context Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$13.03-$8.68-$14.56-$7.62
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A33.38%-67.74%47.66%

Context Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$14.84-$23.96-$26.73-$36.12
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-61.46%-11.56%-35.13%

Context Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.140.230.020.11
Current Assets68.3597.916.0537.85
Total Assets68.4998.1316.0637.97
Non Current Liabilities0.00.110.00.0
Current Liabilities8.022.754.193.21
Total Liabilities8.022.864.193.21
Shareholders' Equity60.4795.2711.8734.76

Context Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-26.39-14.56-21.05-14.05
Investing-2.03-14.760.0-0.04
Financing-0.02109.290.0-0.1

About Context

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Context Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.19
$0.16
-14.74%
Oct 2026
$0.31
$0.19
-36.67%
Sep 2026
$0.39
$0.30
-27.54%
Aug 2026
$0.61
$0.41
-30.65%
Jul 2026
$0.57
$0.60
+8.55%
Jun 2026
$2.83
$0.55
-80.77%
May 2026
$2.32
$2.86
+21.19%
Apr 2026
$2.71
$2.36
-10.27%
Mar 2026
$2.14
$2.63
+16.37%
Feb 2026
$2.68
$2.26
-13.90%
Jan 2026
$1.47
$2.63
+79.79%
Dec 2025
$1.09
$1.46
+30.36%

Context Share Price FAQs